Literature DB >> 1937930

Effect of histamine on tumor necrosis factor production by human monocytes.

G Hotermans1, T Bury, M F Radermecker.   

Abstract

This study was aimed at evaluating the effect of histamine on tumor necrosis factor (TNF alpha) secretion by purified human blood monocytes. TNF alpha was measured by radioimmunoassay. Histamine caused a dose-dependent inhibition of lipopolysaccharide-induced TNF alpha production from human blood monocytes, averaging maximally 50% at 10(-5) M. Preincubation of mononuclear cells with an H2 antagonist (cimetidine), but not with an H1 antagonist (promethazine) prevented this inhibitory effect of histamine. In conclusion, histamine causes, in vitro, a depression of TNF alpha secretion by human monocytes through activation of H2 receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937930     DOI: 10.1159/000235442

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  5 in total

1.  Macrophages and lymphocytes: alternative sources of histamine.

Authors:  G Zwadlo-Klarwasser; U Braam; P Mühl-Zürbes; W Schmutzler
Journal:  Agents Actions       Date:  1994-06

Review 2.  The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1996-09       Impact factor: 6.968

Review 3.  Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

4.  Effects of neurotoxic lesions in histaminergic neurons on brain tumor necrosis factor levels.

Authors:  X A Alvarez; A Franco; L Fernández-Novoa; R Cacabelos
Journal:  Agents Actions       Date:  1994-06

5.  Effects of histamine and alpha-fluoromethylhistidine on brain tumor necrosis factor levels in rats.

Authors:  L Fernández-Novoa; A Franco-Maside; X A Alvarez; R Cacabelos
Journal:  Inflamm Res       Date:  1995-01       Impact factor: 4.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.